What is Haemonetics's price / sales?

Haemonetics (HAE) reported price / sales of 2× in Q1 2026.

How has Haemonetics's price / sales changed year-over-year?

Haemonetics's price / sales decreased by 16.3% year-over-year, from 2.3× to 2×.

What is the long-term trend for Haemonetics's price / sales?

Over 5 years (2021 to 2026), Haemonetics's price / sales has grown at a -21.3% compound annual growth rate (CAGR), from 6.5× to 2×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Haemonetics HAE Price / sales

Price / sales at other companies

AbbottABT

4×-1.5×

TFX

TeleflexTFX

2.5×-1.1×

Boston ScientificBSX

4.5×-4.0×

MedtronicMDT

2.9×-0.4×

LivaNovaLIVN

2.4×+0.8×

ICU MedicalICUI

1.5×+0.1×

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

market cap/total revenue=2×

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's price / sales?: Haemonetics (HAE) reported price / sales of 2× in Q1 2026.
How has Haemonetics's price / sales changed year-over-year?: Haemonetics's price / sales decreased by 16.3% year-over-year, from 2.3× to 2×.
What is the long-term trend for Haemonetics's price / sales?: Over 5 years (2021 to 2026), Haemonetics's price / sales has grown at a -21.3% compound annual growth rate (CAGR), from 6.5× to 2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.